Paradigm Biopharmaceuticals Limited (ASX:PAROA)

Market Cap	148.25M +80.1%
Revenue (ttm)	n/a
Net Income	-18.77M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,046,010
Average Volume	708,026
Open	0.0020
Previous Close	0.0020
Day's Range	0.0010 - 0.0020
52-Week Range	0.0010 - 0.2450
Beta	n/a
RSI	35.27
Earnings Date	Nov 27, 2025

About ASX:PAROA

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PAROA